US 11273131
Pharmaceutical compositions with enhanced permeation
granted A61KA61K31/05A61K31/085
Quick answer
US patent 11273131 (Pharmaceutical compositions with enhanced permeation) held by Aquestive Therapeutics, Inc. expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aquestive Therapeutics, Inc.
- Grant date
- Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 58
- CPC classes
- A61K, A61K31/05, A61K31/085, A61K31/137, A61K31/335